Why Moderna Is Shooting Higher Today
Coronavirus stock Moderna (NASDAQ: MRNA) was up by nearly 8% in mid-afternoon trading on Thursday. Two pieces of news about the company's coronavirus vaccine seem to be supporting this rise. The first is Moderna's announcement that dosing of participants has begun in a phase 1/2 clinical trial for mRNA-1273 in Japan.